According to China Resources Pharmaceutical Group's latest financial reports the company's current revenue (TTM ) is €30.34 Billion. In 2022 the company made a revenue of €30.34 Billion an increase over the revenue in the year 2021 that were of €28.34 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.